GreenSky Ventures

GreenSky Capital is a Toronto-based private equity and venture capital firm founded in 2010, focusing on early-stage investments primarily in the technology sector. The firm specializes in information technology, clean technology, and medical technology, aiming to support high-growth potential companies and dedicated entrepreneurs. GreenSky Capital manages several affiliated venture capital funds, including the GreenSky Accelerator Fund I, II, III, and IV, which target various sectors such as financial services, consumer products, and information technology. The firm’s leadership brings a blend of expertise in technology, law, and finance, enabling them to provide both capital and financial advisory services to emerging businesses in Canada.

Marian Hoffmann

Managing Partner

Michael T. R. List

Principal

Neil Peet

Senior Associate

Nadine Rijkhoff

Principal

Greg Stewart

Managing Partner

Gregory Stewart

Principal

Past deals in Toronto

Wisedocs

Seed Round in 2022
Rethinking Medical Assessments.

Funnelytics

Seed Round in 2022
Funnelytics Inc., founded in 2017 and based in Toronto, Canada, specializes in developing a funnel mapping and analytics tool tailored for digital marketers. The software allows users to design, track, and analyze marketing funnels, enabling a more effective approach to marketing analysis. Funnelytics provides features that allow enterprises to create custom funnels or utilize existing templates, facilitating the measurement of performance across various channels. Users can estimate campaign conversion rates, assess expenses and traffic volumes, and calculate profit and return on investment. This functionality empowers marketers and business owners to visually map and track their sales and marketing campaigns, ultimately enhancing their overall marketing effectiveness.

PhenoTips

Seed Round in 2021
PhenoTips is a computer software company that provides solution for clinical genetics, phenotyping, and human phenotype ontology. It offers smart software solutions streamlined for clinical use that can be integrated with existing electronic health records. The company was founded in 2014 and headquartered in Ontario, Canada.

Cyclica

Series B in 2020
Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Funnelytics

Seed Round in 2020
Funnelytics Inc., founded in 2017 and based in Toronto, Canada, specializes in developing a funnel mapping and analytics tool tailored for digital marketers. The software allows users to design, track, and analyze marketing funnels, enabling a more effective approach to marketing analysis. Funnelytics provides features that allow enterprises to create custom funnels or utilize existing templates, facilitating the measurement of performance across various channels. Users can estimate campaign conversion rates, assess expenses and traffic volumes, and calculate profit and return on investment. This functionality empowers marketers and business owners to visually map and track their sales and marketing campaigns, ultimately enhancing their overall marketing effectiveness.

Trolley

Venture Round in 2020
Payment Rails is an API first payouts platform for businesses and platforms to pay on-demand workers globally.

Rank

Private Equity Round in 2019
Rank Software Inc. is a cybersecurity technology company based in Toronto, Canada, specializing in a unified threat analytics platform designed for incident response. Founded in 2013, the company focuses on developing advanced security analytics solutions, including RANK Sagumen, which offers capabilities for incident response, malware analysis, email screening, and security audits. The platform helps users detect, contextualize, and prioritize various cyber threats, including advanced persistent threats and insider attacks. Rank serves a diverse clientele, including telecom operators, and distributes its products through resellers and integrators. In 2020, Rank Software was acquired by Arctic Wolf Networks, enhancing its reach and capabilities in the cybersecurity landscape.

Cyclica

Venture Round in 2019
Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Brickeye

Series A in 2018
AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments and heavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently.

Trolley

Convertible Note in 2018
Payment Rails is an API first payouts platform for businesses and platforms to pay on-demand workers globally.

Nanovista

Seed Round in 2018
Nanovista is focused on improving patient outcomes by enhancing intraoperative visualization during cancer therapies. The company has developed a multimodal visualization agent that significantly aids in the performance of image-guided, high-precision cancer treatments. Their technology enables safe visualization of tumors and malignant lymph nodes across various preclinical solid tumor models. It offers a prolonged imaging window that is effective for both pre-operative and intra-operative imaging. Utilizing computed tomography and fluorescence optical imaging following a single administration, Nanovista's solutions assist doctors and surgeons in accurately identifying and localizing tumor lesions, thereby improving the precision of cancer interventions.

Cyclica

Series A in 2017
Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Right Health

Seed Round in 2017
Right Health was founded with a vision of providing a combination of virtual and face-to-face care to optimize the health and engagement of Canadians. Right Health has partnered with leading healthcare providers to facilitate easy patient access through a consumer-facing portal and app, linked with a patient’s electronic medical record.

Brickeye

Seed Round in 2017
AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments and heavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently.

Brickeye

Seed Round in 2016
AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments and heavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently.

Cyclica

Series A in 2016
Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Limelight

Seed Round in 2016
Limelight Platform, Inc. is a Toronto-based company that specializes in providing tools for automated, data-driven live marketing campaigns. Its software-as-a-service (SaaS) platform offers a range of features, including live strategy development, activation tools, consumer communication, social amplification, and real-time data analysis. These capabilities enable businesses to effectively manage and measure live marketing initiatives, enhancing customer engagement while reducing costs and improving sales outcomes. Limelight’s solutions cater to various marketing activities, including mall tours, contests, events, experiential marketing, in-store experiences, kiosks, samplings, sponsorships, and test drives. Founded in 2014 by Jonah Midanik and Russ Armstrong, Limelight Platform aims to revolutionize how brands connect with their audiences through interactive and engaging experiences.

Cyclica

Venture Round in 2015
Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Clear Blue Technologies

Non Equity Assistance in 2015
Clear Blue Technologies International Inc. specializes in off-grid power solutions that integrate renewable energy with advanced communication and cloud technology. The company develops and sells products designed to power, control, and manage solar and hybrid systems, primarily serving applications such as street lights, security systems, telecommunications, emergency power, and Internet of Things (IoT) devices. Its offerings include solar and wind controllers, telecom solar power systems, illumience cloud controls, Nano-grid power packs, and solar-powered outdoor lighting systems marketed under the Illumient brand. Additionally, Clear Blue provides remote power management services to enhance the reliability and efficiency of these systems. Headquartered in Toronto, Canada, the company operates across Canada, the United States, the Middle East, and Africa.

ExactFlat

Series B in 2013
ExactFlat, a division of Tri-D Technologies Inc. based in Toronto, Canada, specializes in software that transforms 3D CAD designs into 2D flat patterns suitable for cutting. Its platform facilitates the conversion of three-dimensional objects into flat patterns and production templates, particularly benefiting the textile industry by enabling the design of sewing patterns directly from 3D models. Additionally, the software includes tools for calculating and adjusting material costs, streamlining the fabrication process for products made from composites.

Wave

Seed Round in 2011
Wave is a financial management company that specializes in providing online software solutions for small businesses. Founded in 2009 and headquartered in Toronto, Canada, Wave offers a comprehensive suite of services including accounting, invoicing, payroll, and payment processing. With over 3 million users in more than 200 countries, Wave is dedicated to enhancing the operational efficiency of micro and small businesses by helping them manage their finances effectively. The platform enables business owners to improve cash flow and streamline financial tasks, allowing them to focus on growth and sustainability.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.